HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Deleted in colorectal cancer is a putative conditional tumor-suppressor gene inactivated by promoter hypermethylation in head and neck squamous cell carcinoma.

Abstract
Deleted in colorectal cancer (DCC) is a candidate tumor-suppressor gene located at chromosome 18q21. However, DCC gene was found to have few somatic mutations and the heterozygous mice (DCC(+/-)) showed a similar frequency of tumor formation compared with the wild-type mice (DCC(+/+)). Recently, DCC came back to the spotlight as a better understating of its function and relationship with its ligand (netrin-1) had shown that DCC may act as a conditional tumor-suppressor gene. We evaluated hypermethylation as a mechanism for DCC inactivation in head and neck squamous cell carcinoma (HNSCC). DCC promoter region hypermethylation was found in 75% of primary HNSCC. There was a significant correlation between DCC promoter region hypermethylation and DCC expression (assessed by immunohistochemistry; P = 0.021). DCC nonexpressing HNSCC cell lines JHU-O12 and JHU-O19 with baseline hypermethylation of the DCC promoter were treated with 5-aza-2'-deoxycytidine (a demethylating agent) and reexpression of DCC was noted. Transfection of DCC into DCC-negative HNSCC cell lines resulted in complete abrogation of growth in all cell lines, whereas additional cotransfection of netrin-1 resulted in rescue of DCC-mediated growth inhibition. These results suggest that DCC is a putative conditional tumor-suppressor gene that is epigenetically inactivated by promoter hypermethylation in a majority of HNSCC.
AuthorsAndré Lopes Carvalho, Alice Chuang, Wei-Wen Jiang, Juna Lee, Shahnaz Begum, Luana Poeta, Ming Zhao, Carmen Jerónimo, Rui Henrique, Chetan S Nayak, Hannah L Park, Mariana R O Brait, Chunyan Liu, Shaoyu Zhou, Wayne Koch, Vito Michele Fazio, Edward Ratovitski, Barry Trink, William Westra, David Sidransky, Chul-so Moon, Joseph A Califano
JournalCancer research (Cancer Res) Vol. 66 Issue 19 Pg. 9401-7 (Oct 01 2006) ISSN: 1538-7445 [Electronic] United States
PMID17018594 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • DCC Receptor
  • DCC protein, human
  • DNA, Neoplasm
  • NTN1 protein, human
  • Neoplasm Proteins
  • Nerve Growth Factors
  • Ntn1 protein, mouse
  • Receptors, Cell Surface
  • Tumor Suppressor Proteins
  • Netrin-1
Topics
  • Carcinoma, Squamous Cell (genetics, pathology)
  • Cell Line, Tumor
  • CpG Islands (genetics)
  • DCC Receptor
  • DNA Methylation
  • DNA, Neoplasm (chemistry, genetics)
  • Gene Expression Regulation, Neoplastic
  • Genes, DCC
  • Head and Neck Neoplasms (genetics, pathology)
  • Humans
  • Loss of Heterozygosity
  • Neoplasm Proteins (biosynthesis, deficiency, genetics, physiology)
  • Nerve Growth Factors (genetics, physiology)
  • Netrin-1
  • Promoter Regions, Genetic (genetics)
  • Receptors, Cell Surface (biosynthesis, deficiency, physiology)
  • Transfection
  • Tumor Suppressor Proteins (biosynthesis, deficiency, genetics, physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: